Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study

OBJECTIVES: We assessed the virologic efficacy of switching to co-formulated elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate (E/C/F/TDF) in patients with controlled HIV infection. METHODS: We conducted a retrospective multicenter observational cohort study including adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales: De Castro, Nathalie, Brun, Alexandre, Sellier, Pierre, Hamet, Gwenn, Mechaï, Frédéric, Garrait, Valérie, Chabrol, Amélie, Bouldouyre, Marie-Anne, Froguel, Eric, Troisvallets, Didier, Caraux-Paz, Pauline, Delaugerre, Constance, Rozenbaum, Willy, Molina, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809122/
https://www.ncbi.nlm.nih.gov/pubmed/36597160
http://dx.doi.org/10.1186/s12981-022-00499-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809122/
https://www.ncbi.nlm.nih.gov/pubmed/36597160
http://dx.doi.org/10.1186/s12981-022-00499-4

Ejemplares similares